
|
Number 03 - MARCH
2006 COLORECTAL CANCER - METASTATIC DISEASE Homsi J, Garrett CR. Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer. Cancer Control. 2006 Jan-Feb;13(1):42-7.
Kemeny NE, Niedzwiecki D,
Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER,
Herndon JE 2nd, Zhang C, Mayer RJ.
Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic
Metastases From Colorectal Cancer: A Randomized Trial of Efficacy,
Quality of Life, and Molecular Markers (CALGB 9481). Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol. 2006 Mar;13(3):353-62.
Masi G, Cupini S, Marcucci L, Cerri E,
Loupakis F, Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O,
Filipponi F, Falcone A.
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and
irinotecan enables surgical resection of metastases in patients with
initially unresectable metastatic colorectal cancer. Shimada H, Tanaka K, Matsuo K, Togo S. Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg. 2005 Dec 1;:1-13 |